|
|
|
Insider
Information: |
Hedley Mary Lynne |
Relationship: |
Director |
City: |
Lexington |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
34,607 |
|
Indirect Shares
|
98 |
|
|
Direct
Value |
$2,029,187 |
|
|
Indirect Value
|
$74,480 |
|
|
Total
Shares |
34,705 |
|
|
Total
Value |
$2,103,667 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
MGI Pharma Inc |
MOGN |
Exec VP & Chief Scient... |
2008-01-28 |
0 |
2008-01-23 |
0 |
Premium* |
|
New Abraxis Inc |
ABII |
Executive VP of Ops & ... |
2009-07-13 |
25,000 |
2009-07-13 |
0 |
Premium* |
|
Tesaro, Inc. |
TSRO |
President & COO, Direc... |
2019-01-22 |
0 |
2019-01-22 |
0 |
Premium* |
|
Receptos, Inc. |
RCPT |
Director |
2015-08-27 |
0 |
2015-05-28 |
0 |
Premium* |
|
Bluebird Bio, Inc. |
BLUE |
Director |
2018-06-20 |
3,700 |
2017-09-18 |
0 |
Premium* |
|
Veeva Systems Inc |
VEEV |
Director |
2024-03-01 |
4,430 |
2019-11-16 |
0 |
Premium* |
|
Eli Lilly & Co |
LLY |
Director |
2024-04-15 |
1,477 |
2024-04-15 |
98 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
77 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MOGN |
MGI Pharma Inc |
Sr. VP & Chief Scientific Off |
|
2005-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
|
- |
|
MOGN |
MGI Pharma Inc |
Sr. VP & Chief Scientific Off |
|
2006-07-15 |
4 |
D |
$20.58 |
$5,701 |
D/D |
(277) |
3,223 |
|
- |
|
MOGN |
MGI Pharma Inc |
Exec VP & Chief Scientific Off |
|
2006-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
26,223 |
|
- |
|
MOGN |
MGI Pharma Inc |
Exec VP & Chief Scientific Off |
|
2006-09-03 |
4 |
D |
$15.06 |
$35,858 |
D/D |
(2,381) |
23,842 |
0 |
- |
|
MOGN |
MGI Pharma Inc |
Exec VP & Chief Scientific Off |
|
2006-10-03 |
4 |
D |
$17.21 |
$4,096 |
D/D |
(238) |
23,604 |
0 |
- |
|
MOGN |
MGI Pharma Inc |
Exec VP & Chief Scientific Off |
|
2007-07-15 |
4 |
D |
$25.37 |
$7,053 |
D/D |
(278) |
34,826 |
0 |
- |
|
MOGN |
MGI Pharma Inc |
Exec VP & Chief Scientific Off |
|
2007-08-31 |
4 |
D |
$23.57 |
$37,406 |
D/D |
(1,587) |
33,239 |
0 |
- |
|
MOGN |
MGI Pharma Inc |
Exec VP & Chief Scientific Off |
|
2008-01-23 |
4 |
D |
$41.00 |
$75,235 |
I/I |
(1,835) |
0 |
0 |
- |
|
MOGN |
MGI Pharma Inc |
Exec VP & Chief Scientific Off |
|
2008-01-23 |
4 |
D |
$41.00 |
$614,549 |
D/D |
(14,989) |
18,250 |
0 |
- |
|
MOGN |
MGI Pharma Inc |
Exec VP & Chief Scientific Off |
|
2008-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
18,083 |
36,333 |
0 |
- |
|
MOGN |
MGI Pharma Inc |
Exec VP & Chief Scientific Off |
|
2008-01-28 |
4 |
D |
$41.00 |
$1,489,653 |
D/D |
(36,333) |
0 |
0 |
- |
|
ABII |
New Abraxis Inc |
Executive VP of Ops & CSO |
|
2009-07-13 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
TSRO |
Tesaro, Inc. |
Pres.&Chief Scientific Officer |
|
2012-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
71,428 |
563,569 |
0 |
- |
|
RCPT |
Receptos, Inc. |
Director |
|
2015-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,400 |
7,400 |
0 |
- |
|
RCPT |
Receptos, Inc. |
Director |
|
2015-08-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,400) |
0 |
0 |
- |
|
BLUE |
Bluebird Bio, Inc. |
Director |
|
2017-09-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,700 |
2,700 |
0 |
- |
|
TSRO |
Tesaro, Inc. |
President & COO |
|
2018-03-01 |
4 |
AS |
$54.86 |
$211,485 |
D/D |
(3,855) |
14,998 |
0 |
- |
|
TSRO |
Tesaro, Inc. |
President & COO |
|
2018-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,780 |
18,853 |
0 |
- |
|
BLUE |
Bluebird Bio, Inc. |
Director |
|
2018-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
3,700 |
0 |
- |
|
TSRO |
Tesaro, Inc. |
President & COO |
|
2018-12-20 |
4 |
OE |
$6.62 |
$154,725 |
D/D |
23,390 |
38,388 |
0 |
- |
|
TSRO |
Tesaro, Inc. |
President & COO |
|
2018-12-20 |
4 |
D |
$73.10 |
$845,913 |
D/D |
(11,572) |
26,816 |
0 |
- |
|
TSRO |
Tesaro, Inc. |
President & COO |
|
2019-01-22 |
4 |
D |
$75.00 |
$2,011,200 |
D/D |
(26,816) |
0 |
0 |
- |
|
TSRO |
Tesaro, Inc. |
President & COO |
|
2019-01-22 |
4 |
D |
$75.00 |
$42,267,675 |
I/I |
(563,569) |
0 |
0 |
- |
|
VEEV |
Veeva Systems Inc |
Director |
|
2019-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
340 |
340 |
0 |
- |
|
VEEV |
Veeva Systems Inc |
Director |
|
2020-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
341 |
681 |
0 |
- |
|
77 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|